Biotech News
Kura Oncology to Report Fourth Quarter and Full Year 2025 Financial Results
ir.kuraoncology.com2026-05-06 14:56 EST
SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced it will report fourth quarter and full year 2025 financial results on Thursday, March